SHOX Haploinsufficiency as a Cause of Syndromic and Nonsyndromic Short Stature
- PMID: 27194967
- PMCID: PMC4862394
- DOI: 10.1159/000444596
SHOX Haploinsufficiency as a Cause of Syndromic and Nonsyndromic Short Stature
Abstract
SHOX in the short arm pseudoautosomal region (PAR1) of sex chromosomes is one of the major growth genes in humans. SHOX haploinsufficiency results in idiopathic short stature and Léri-Weill dyschondrosteosis and is associated with the short stature of patients with Turner syndrome. The SHOX protein likely controls chondrocyte apoptosis by regulating multiple target genes including BNP,Fgfr3, Agc1, and Ctgf. SHOX haploinsufficiency frequently results from deletions and duplications in PAR1 involving SHOX exons and/or the cis-acting enhancers, while exonic point mutations account for a small percentage of cases. The clinical severity of SHOX haploinsufficiency reflects hormonal conditions rather than mutation types. Growth hormone treatment seems to be beneficial for cases with SHOX haploinsufficiency, although the long-term outcomes of this therapy require confirmation. Future challenges in SHOX research include elucidating its precise function in the developing limbs, identifying additional cis-acting enhancers, and determining optimal therapeutic strategies for patients.
Keywords: Bone; Léri-Weill syndrome; Mutation; Pseudoautosomal region; Short stature; Skeletal deformity; Turner syndrome.
Figures



Similar articles
-
Duplications upstream and downstream of SHOX identified as novel causes of Leri-Weill dyschondrosteosis or idiopathic short stature.Am J Med Genet A. 2016 Apr;170A(4):949-57. doi: 10.1002/ajmg.a.37524. Epub 2015 Dec 24. Am J Med Genet A. 2016. PMID: 26698168
-
[From gene to disease; from SHOX to Lèri-Weill dyschondrosteosis, Turner syndrome and idiopathic short stature].Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1456-9. Ned Tijdschr Geneeskd. 2001. PMID: 11503314 Review. Dutch.
-
Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer.J Med Genet. 2012 Jul;49(7):442-50. doi: 10.1136/jmedgenet-2011-100678. J Med Genet. 2012. PMID: 22791839
-
A Leri-Weill dyschondrosteosis patient confirmed by mutation analysis of SHOX gene.Ann Pediatr Endocrinol Metab. 2015 Sep;20(3):162-5. doi: 10.6065/apem.2015.20.3.162. Epub 2015 Sep 30. Ann Pediatr Endocrinol Metab. 2015. PMID: 26512353 Free PMC article.
-
[Short stature caused by SHOX gene haploinsufficiency: from diagnosis to treatment].Arq Bras Endocrinol Metabol. 2008 Jul;52(5):765-73. doi: 10.1590/s0004-27302008000500008. Arq Bras Endocrinol Metabol. 2008. PMID: 18797583 Review. Portuguese.
Cited by
-
Turner Syndrome where are we?Orphanet J Rare Dis. 2024 Aug 28;19(1):314. doi: 10.1186/s13023-024-03337-0. Orphanet J Rare Dis. 2024. PMID: 39198906 Free PMC article. Review.
-
Heterozygous Deletion of the SHOX Gene Enhancer in two Females With Clinical Heterogeneity Associating With Skewed XCI and Escaping XCI.Front Genet. 2019 Nov 6;10:1086. doi: 10.3389/fgene.2019.01086. eCollection 2019. Front Genet. 2019. PMID: 31781162 Free PMC article.
-
Copy Number Variation and Structural Genomic Findings in 116 Cases of Sudden Unexplained Death between 1 and 28 Months of Age.Adv Genet (Hoboken). 2022 Nov 7;4(1):2200012. doi: 10.1002/ggn2.202200012. eCollection 2023 Mar. Adv Genet (Hoboken). 2022. PMID: 36910592 Free PMC article.
-
Heterozygous NPR2 Mutation in Two Family Members with Short Stature and Skeletal Dysplasia.Case Rep Endocrinol. 2018 Nov 28;2018:7658496. doi: 10.1155/2018/7658496. eCollection 2018. Case Rep Endocrinol. 2018. PMID: 30622824 Free PMC article.
-
Efficacy and safety of GH treatment in Japanese children with short stature due to SHOX deficiency: a randomized phase 3 study.Clin Pediatr Endocrinol. 2024;33(2):43-49. doi: 10.1297/cpe.2023-0070. Epub 2024 Jan 28. Clin Pediatr Endocrinol. 2024. PMID: 38572386 Free PMC article.
References
-
- Aza-Carmona M, Shears DJ, Yuste-Checa P, Barca-Tierno V, Hisado-Oliva A, et al. SHOX interacts with the chondrogenic transcription factors SOX5 and SOX6 to activate the aggrecan enhancer. Hum Mol Genet. 2011;20:1547–1559. - PubMed
-
- Belin V, Cusin V, Viot G, Girlich D, Toutain A, et al. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet. 1998;19:67–69. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous